FEED Validator

Congratulations!

This is a valid RSS feed.

Recommendations

This feed is valid, but interoperability with the widest range of feed readers could be improved by implementing the following recommendations.

• line 2, column 0: Use of unknown namespace: http://prismstandard.org/namespaces/1.2/basic/ [help]

  <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  

• line 2, column 0: Use of unknown namespace: http://www.w3.org/2001/XMLSchema-instance [help]

  <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
  

Source: http://www.mayoclinicproceedings.org/current.rss

1. <?xml version="1.0" encoding="UTF-8"?>
2. <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
3.         xmlns="http://purl.org/rss/1.0/"
4.         xmlns:dc="http://purl.org/dc/elements/1.1/"
5.         xmlns:dcterms="http://purl.org/dc/terms/"
6.         xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
7.         xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
8.         xsi:schemaLocation="http://www.w3.org/1999/02/22-rdf-syntax-ns# uri:atypon.com:cms:schema:rdf.xsd">
9.   <channel rdf:about="https://www.mayoclinicproceedings.org/issues?publicationCode=jmcp&amp;rss=yes">
10.      <title>Mayo Clinic Proceedings</title>
11.      <description>Mayo Clinic Proceedings RSS feed. </description>
12.      <link>https://www.mayoclinicproceedings.org/issues?publicationCode=jmcp&amp;rss=yes</link>
13.      <dc:publisher>Elsevier Inc.</dc:publisher>
14.      <dc:language>en</dc:language>
15.      <dc:rights>© 2024 Published by Elsevier Inc. All rights reserved.</dc:rights>
16.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
17.      <prism:issn>0025-6196</prism:issn>
18.      <prism:publicationDate>2024-05-17-07:00</prism:publicationDate>
19.      <prism:copyright>© 2024 Published by Elsevier Inc. All rights reserved.</prism:copyright>
20.      <prism:rightsAgent>permissionshelpdesk@elsevier.com</prism:rightsAgent>
21.      <items>
22.         <rdf:Seq>
23.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00106-X/fulltext?rss=yes"/>
24.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00096-X/fulltext?rss=yes"/>
25.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00093-4/fulltext?rss=yes"/>
26.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00030-2/fulltext?rss=yes"/>
27.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00090-9/fulltext?rss=yes"/>
28.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00609-2/fulltext?rss=yes"/>
29.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00104-6/fulltext?rss=yes"/>
30.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00086-7/fulltext?rss=yes"/>
31.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00600-6/fulltext?rss=yes"/>
32.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00087-9/fulltext?rss=yes"/>
33.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00055-7/fulltext?rss=yes"/>
34.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00051-X/fulltext?rss=yes"/>
35.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00028-4/fulltext?rss=yes"/>
36.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00052-1/fulltext?rss=yes"/>
37.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00606-7/fulltext?rss=yes"/>
38.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00599-2/fulltext?rss=yes"/>
39.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00564-5/fulltext?rss=yes"/>
40.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00476-7/fulltext?rss=yes"/>
41.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00406-8/fulltext?rss=yes"/>
42.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00610-9/fulltext?rss=yes"/>
43.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00037-5/fulltext?rss=yes"/>
44.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00466-4/fulltext?rss=yes"/>
45.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00035-1/fulltext?rss=yes"/>
46.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00602-X/fulltext?rss=yes"/>
47.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00568-2/fulltext?rss=yes"/>
48.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00367-1/fulltext?rss=yes"/>
49.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00358-0/fulltext?rss=yes"/>
50.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00453-6/fulltext?rss=yes"/>
51.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00412-3/fulltext?rss=yes"/>
52.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00451-2/fulltext?rss=yes"/>
53.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00414-7/fulltext?rss=yes"/>
54.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00413-5/fulltext?rss=yes"/>
55.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00572-4/fulltext?rss=yes"/>
56.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00026-0/fulltext?rss=yes"/>
57.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00341-5/fulltext?rss=yes"/>
58.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00469-X/fulltext?rss=yes"/>
59.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00304-X/fulltext?rss=yes"/>
60.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00356-7/fulltext?rss=yes"/>
61.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00373-7/fulltext?rss=yes"/>
62.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00347-6/fulltext?rss=yes"/>
63.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00195-2/fulltext?rss=yes"/>
64.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00173-3/fulltext?rss=yes"/>
65.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00172-1/fulltext?rss=yes"/>
66.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00171-X/fulltext?rss=yes"/>
67.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00162-9/fulltext?rss=yes"/>
68.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00161-7/fulltext?rss=yes"/>
69.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00147-2/fulltext?rss=yes"/>
70.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00136-8/fulltext?rss=yes"/>
71.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00135-6/fulltext?rss=yes"/>
72.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00134-4/fulltext?rss=yes"/>
73.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00107-1/fulltext?rss=yes"/>
74.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00088-0/fulltext?rss=yes"/>
75.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00083-1/fulltext?rss=yes"/>
76.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00054-5/fulltext?rss=yes"/>
77.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00053-3/fulltext?rss=yes"/>
78.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00048-X/fulltext?rss=yes"/>
79.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00033-8/fulltext?rss=yes"/>
80.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00032-6/fulltext?rss=yes"/>
81.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00601-8/fulltext?rss=yes"/>
82.            <rdf:li rdf:resource="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00422-6/fulltext?rss=yes"/>
83.         </rdf:Seq>
84.      </items>
85.   </channel>
86.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00106-X/fulltext?rss=yes">
87.      <title>Cowden Syndrome—Oral Finding</title>
88.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00106-X/fulltext?rss=yes</link>
89.      <description>Cowden syndrome is a rare autosomal dominant disease known to affect multiple organs, with a higher risk of malignancy and benign hamartomatous growths throughout the body. The syndrome is caused by a genetic mutation in the PTEN gene that is responsible for tumor suppression through suppression of cellular growth velocity and accurate division of cells throughout the body.1</description>
90.      <dc:title>Cowden Syndrome—Oral Finding</dc:title>
91.      <dc:creator>Ashley M. Stantz, Jamie S. Newman</dc:creator>
92.      <dc:identifier>10.1016/j.mayocp.2024.02.020</dc:identifier>
93.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
94.      <dc:date>2024-05-17</dc:date>
95.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
96.      <prism:publicationDate>2024-05-17</prism:publicationDate>
97.      <prism:section>Medical image</prism:section>
98.   </item>
99.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00096-X/fulltext?rss=yes">
100.      <title>Discordance Between Mucosal Appearances and Pathologic Findings in Intestinal Mycobacterial Infection in an Immunocompromised Patient</title>
101.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00096-X/fulltext?rss=yes</link>
102.      <description>A man in his early 50s with dermatomyositis, interstitial pneumonia, and lower limb venous thrombosis was admitted to our hospital with intermittent intestinal bleeding of 1 month’s duration. He was being treated with prednisolone (18 mg/d), tacrolimus (7 mg/d), azathioprine (50 mg/d), iguratimod (25 mg/d), and edoxaban (30 mg/d). On admission, he had no abdominal pain. Laboratory findings included a hemoglobin level of 5.4 g/dL and negative results for HIV antibody. Esophagogastroduodenoscopy revealed a normal duodenal mucosal surface; however, it bled with irrigation alone (Figure 1).</description>
103.      <dc:title>Discordance Between Mucosal Appearances and Pathologic Findings in Intestinal Mycobacterial Infection in an Immunocompromised Patient</dc:title>
104.      <dc:creator>Daisuke Tsukui, Toshihiro Haga, Koichiro Abe</dc:creator>
105.      <dc:identifier>10.1016/j.mayocp.2024.02.012</dc:identifier>
106.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
107.      <dc:date>2024-05-17</dc:date>
108.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
109.      <prism:publicationDate>2024-05-17</prism:publicationDate>
110.      <prism:section>Medical image</prism:section>
111.   </item>
112.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00093-4/fulltext?rss=yes">
113.      <title>A Focal Chronic Myopathic Form of Muscular Sarcoidosis</title>
114.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00093-4/fulltext?rss=yes</link>
115.      <description>A woman in her 70s with sarcoidosis presented with a 9-month history of slowly progressive gait disturbance. Laboratory findings revealed elevated levels of creatine kinase (CK) (1595 U/L; normal, 41 to 153 U/L) and aldolase (9.6 U/L; normal, 2.1 to 6.1 U/L). Neurologic examination revealed moderate weakness and mild diffuse swelling of the right gastrocnemius muscle. Lower-leg magnetic resonance imaging (MRI) revealed hyperintensity of the right gastrocnemius on short-tau inversion recovery imaging (arrows in Figures 1A and 1B).</description>
116.      <dc:title>A Focal Chronic Myopathic Form of Muscular Sarcoidosis</dc:title>
117.      <dc:creator>Daisuke Suzuki, Fumiaki Uchimura, Akiko Nishida</dc:creator>
118.      <dc:identifier>10.1016/j.mayocp.2024.02.009</dc:identifier>
119.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
120.      <dc:date>2024-05-17</dc:date>
121.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
122.      <prism:publicationDate>2024-05-17</prism:publicationDate>
123.      <prism:section>Medical image</prism:section>
124.   </item>
125.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00030-2/fulltext?rss=yes">
126.      <title>73-Year-Old Woman With Fatigue</title>
127.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00030-2/fulltext?rss=yes</link>
128.      <description>A 73-year-old woman presented to the emergency department with worsening fatigue, dizziness, and generalized weakness of 2 weeks’ duration. Her medical comorbidities included heart failure with preserved ejection fraction, prior rheumatic fever complicated by severe mitral valve regurgitation after prosthetic mitral valve replacement, acute ischemic stroke, and a history of gastrointestinal (GI) bleeding. Her medications included rivaroxaban, iron supplementation tablet, metoprolol tartrate, and torsemide.</description>
129.      <dc:title>73-Year-Old Woman With Fatigue</dc:title>
130.      <dc:creator>Joon Korleski, Santiago Martinez-Sosa, Aditya Shah</dc:creator>
131.      <dc:identifier>10.1016/j.mayocp.2023.12.023</dc:identifier>
132.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
133.      <dc:date>2024-05-17</dc:date>
134.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
135.      <prism:publicationDate>2024-05-17</prism:publicationDate>
136.      <prism:section>Residents’ clinic</prism:section>
137.   </item>
138.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00090-9/fulltext?rss=yes">
139.      <title>Oxalate Metabolism: From Kidney Stones to Cardiovascular Disease</title>
140.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00090-9/fulltext?rss=yes</link>
141.      <description>Oxalate kidney stones are common and exert a huge burden of morbidity worldwide. However, circulating or excreted concentrations of oxalate are rarely measured. We argue that oxalate and its metabolism are important above and beyond kidney stone formation. There is emerging evidence that increased concentrations of oxalate could be a driver of chronic kidney disease progression. Furthermore, oxalate has been implicated in cardiovascular disease. Thus, the reduction of elevated plasma oxalate concentrations may represent a novel cardioprotective and nephroprotective strategy.</description>
142.      <dc:title>Oxalate Metabolism: From Kidney Stones to Cardiovascular Disease</dc:title>
143.      <dc:creator>Gerlineke Hawkins-van der Cingel, Stephen B. Walsh, Kai-Uwe Eckardt, Felix Knauf</dc:creator>
144.      <dc:identifier>10.1016/j.mayocp.2024.02.006</dc:identifier>
145.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
146.      <dc:date>2024-05-16</dc:date>
147.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
148.      <prism:publicationDate>2024-05-16</prism:publicationDate>
149.      <prism:section>Understanding Disease</prism:section>
150.   </item>
151.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00609-2/fulltext?rss=yes">
152.      <title>Proton Pump Inhibitor Use and Bone Health in Patients With Rheumatic Diseases: A Cross-Sectional Study</title>
153.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00609-2/fulltext?rss=yes</link>
154.      <description>To assess the effect of proton pump inhibitor (PPI) use on bone mineral density (BMD) and bone microarchitecture as measured by the trabecular bone score (TBS) in patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs).</description>
155.      <dc:title>Proton Pump Inhibitor Use and Bone Health in Patients With Rheumatic Diseases: A Cross-Sectional Study</dc:title>
156.      <dc:creator>Andriko Palmowski, Gabriela Schmajuk, Jinoos Yazdany, Patricia Katz, Jing Li, Rachael Stovall, Emma Kersey, Sabrina M. Nielsen, Robin Christensen, Henning Bliddal, Zhivana Boyadzhieva, Udo Schneider, Tobias Alexander, Burkhard Muche, Sandra Hermann, Edgar Wiebe, Frank Buttgereit</dc:creator>
157.      <dc:identifier>10.1016/j.mayocp.2023.12.008</dc:identifier>
158.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
159.      <dc:date>2024-05-16</dc:date>
160.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
161.      <prism:publicationDate>2024-05-16</prism:publicationDate>
162.      <prism:section>Original article</prism:section>
163.   </item>
164.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00104-6/fulltext?rss=yes">
165.      <title>Trends in California Cardiovascular Disease Mortality: Sex–Race/Ethnicity Disparity and Income Inequality</title>
166.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00104-6/fulltext?rss=yes</link>
167.      <description>To examine the cardiovascular disease (CVD)–related death trends and the relationship between CVD deaths and sex, race/ethnicity, and income in California from January 1, 1999, to December 31, 2021.</description>
168.      <dc:title>Trends in California Cardiovascular Disease Mortality: Sex–Race/Ethnicity Disparity and Income Inequality</dc:title>
169.      <dc:creator>Dharma N. Bhatta, William Bommer</dc:creator>
170.      <dc:identifier>10.1016/j.mayocp.2024.02.018</dc:identifier>
171.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
172.      <dc:date>2024-05-13</dc:date>
173.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
174.      <prism:publicationDate>2024-05-13</prism:publicationDate>
175.      <prism:section>Original article</prism:section>
176.   </item>
177.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00086-7/fulltext?rss=yes">
178.      <title>Blue Rubber Bleb Nevus Syndrome</title>
179.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00086-7/fulltext?rss=yes</link>
180.      <description>A man in his mid-20s presented with papules and nodules over his body that had been present for about 20 years. His family history was unremarkable. Physical examination revealed many bluish-violet papules and nodules of various sizes on his face, trunk (Figures 1 and 2; Supplemental Figures 1 and 2, available online at http://www.mayoclinicproceedings.org), limbs, and feet (Supplemental Figures 3 and 4, available online at http://www.mayoclinicproceedings.org). The lesions were soft with a rubbery consistency and nontender.</description>
181.      <dc:title>Blue Rubber Bleb Nevus Syndrome</dc:title>
182.      <dc:creator>Zheng Gu, Dong-Lai Ma</dc:creator>
183.      <dc:identifier>10.1016/j.mayocp.2024.02.002</dc:identifier>
184.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
185.      <dc:date>2024-05-07</dc:date>
186.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
187.      <prism:publicationDate>2024-05-07</prism:publicationDate>
188.      <prism:section>Medical image</prism:section>
189.   </item>
190.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00600-6/fulltext?rss=yes">
191.      <title>41-Year-Old Woman With Ascites</title>
192.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00600-6/fulltext?rss=yes</link>
193.      <description>A 41-year-old woman presented to the emergency department with 2 weeks of worsening dyspnea on exertion and abdominal swelling. She was becoming short of breath walking to her bathroom. She noticed a yellowish discoloration in her eyes over the past week. The patient was a Mexican immigrant with limited medical records. Reported medical history included atrial flutter, congestive heart failure, cirrhosis, and hypothyroidism. Home medications included furosemide, levothyroxine, propranolol, and spironolactone.</description>
194.      <dc:title>41-Year-Old Woman With Ascites</dc:title>
195.      <dc:creator>Alex P. Danielson, Bibek Saha, Michael W. Cullen</dc:creator>
196.      <dc:identifier>10.1016/j.mayocp.2023.11.025</dc:identifier>
197.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
198.      <dc:date>2024-05-05</dc:date>
199.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
200.      <prism:publicationDate>2024-05-05</prism:publicationDate>
201.      <prism:section>Residents’ clinic</prism:section>
202.   </item>
203.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00087-9/fulltext?rss=yes">
204.      <title>Change in Body Mass Index and Cardiovascular Outcomes in Patients With Cancer</title>
205.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00087-9/fulltext?rss=yes</link>
206.      <description>To investigate the association between body mass index (BMI) changes and the risk of cardiovascular disease (CVD) in patients with cancer.</description>
207.      <dc:title>Change in Body Mass Index and Cardiovascular Outcomes in Patients With Cancer</dc:title>
208.      <dc:creator>Kensuke Ueno, Hidehiro Kaneko, Yuta Suzuki, Akira Okada, Katsuhito Fujiu, Taisuke Jo, Norifumi Takeda, Kentaro Kamiya, Junya Ako, Hiroyuki Morita, Koichi Node, Hideo Yasunaga, Issei Komuro</dc:creator>
209.      <dc:identifier>10.1016/j.mayocp.2024.02.003</dc:identifier>
210.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
211.      <dc:date>2024-05-04</dc:date>
212.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
213.      <prism:publicationDate>2024-05-04</prism:publicationDate>
214.      <prism:section>Original article</prism:section>
215.   </item>
216.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00055-7/fulltext?rss=yes">
217.      <title>Pulmonary Alveolar Microlithiasis in a Patient Requiring Allotransplant</title>
218.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00055-7/fulltext?rss=yes</link>
219.      <description>A woman in her late-50s with a 3-year history of progressive hypoxemic respiratory failure, severe pulmonary hypertension, and right ventricular dysfunction was referred for lung transplant assessment. She noted persistent cough and dyspnea on exertion. Pulmonary function testing demonstrated a severe restrictive defect. High-resolution computed tomography of the thorax showed bilateral diffuse interlobular and intralobular septal thickening and ground-glass opacities with extensive calcific deposits (Figure 1).</description>
220.      <dc:title>Pulmonary Alveolar Microlithiasis in a Patient Requiring Allotransplant</dc:title>
221.      <dc:creator>Suhashini Ganapaty, Chi Wan Koo, Ying-Chun Lo</dc:creator>
222.      <dc:identifier>10.1016/j.mayocp.2024.02.001</dc:identifier>
223.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
224.      <dc:date>2024-04-30</dc:date>
225.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
226.      <prism:publicationDate>2024-04-30</prism:publicationDate>
227.      <prism:section>Medical image</prism:section>
228.   </item>
229.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00051-X/fulltext?rss=yes">
230.      <title>Pseudo-Richter Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma After Temporary Acalabrutinib Interruption</title>
231.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00051-X/fulltext?rss=yes</link>
232.      <description>An elderly male patient underwent right ear resection for basal cell carcinoma. He has a history of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) that was well controlled with acalabrutinib, a Bruton tyrosine kinase inhibitor (BTKI) blocking activation of the B-cell receptor signaling pathway. Acalabrutinib was held for 3 days before and after the procedure. A lymph node was biopsied and showed architectural effacement by a diffuse proliferation of large lymphocytes with round nuclei, fine chromatin, and prominent nucleoli (Figure A and B).</description>
233.      <dc:title>Pseudo-Richter Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma After Temporary Acalabrutinib Interruption</dc:title>
234.      <dc:creator>Min Shi, Ji Yuan</dc:creator>
235.      <dc:identifier>10.1016/j.mayocp.2024.01.015</dc:identifier>
236.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
237.      <dc:date>2024-04-30</dc:date>
238.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
239.      <prism:publicationDate>2024-04-30</prism:publicationDate>
240.      <prism:section>Medical image</prism:section>
241.   </item>
242.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00028-4/fulltext?rss=yes">
243.      <title>Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study</title>
244.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00028-4/fulltext?rss=yes</link>
245.      <description>To evaluate the association between trimethylamine N-oxide (TMAO) and related metabolites with adverse cardiovascular events in a multiethnic urban primary prevention population.</description>
246.      <dc:title>Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study</dc:title>
247.      <dc:creator>Yeela Talmor-Barkan, Jiao Yu, Nancy-Sarah Yacovzada, Nili Schamroth Pravda, Colby Ayers, James A. de Lemos, W.H.Wilson Tang, Stanley L. Hazen, Alon Eisen, Guy Witberg, Ran Kornowski, Ian J. Neeland</dc:creator>
248.      <dc:identifier>10.1016/j.mayocp.2023.12.021</dc:identifier>
249.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
250.      <dc:date>2024-04-26</dc:date>
251.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
252.      <prism:publicationDate>2024-04-26</prism:publicationDate>
253.      <prism:section>Original article</prism:section>
254.   </item>
255.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00052-1/fulltext?rss=yes">
256.      <title>Food and Drug Omnibus Reform Act: A Critical Course Correction</title>
257.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00052-1/fulltext?rss=yes</link>
258.      <description>On December 29, 2022, the Consolidated Appropriations Act, 2023 (Public Law No. 117-328) was signed into law, containing the Food and Drug Omnibus Reform Act of 2022 (FDORA), which introduces significant reforms to the US Food and Drug Administration (FDA).1 This paper highlights select provisions of FDORA that, in our view, have broad implications for the clinical and pharmaceutical sectors, such as promoting clinical trial diversity, revising the accelerated approval process, modernizing clinical trial operations, updating marketing exclusivities, expanding cosmetics regulation, and fortifying infant formula oversight.</description>
259.      <dc:title>Food and Drug Omnibus Reform Act: A Critical Course Correction</dc:title>
260.      <dc:creator>Aditya Narayan, I. Glenn Cohen, Eli Y. Adashi</dc:creator>
261.      <dc:identifier>10.1016/j.mayocp.2024.01.016</dc:identifier>
262.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
263.      <dc:date>2024-04-24</dc:date>
264.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
265.      <prism:publicationDate>2024-04-24</prism:publicationDate>
266.      <prism:section>Perspectives and controversies</prism:section>
267.   </item>
268.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00606-7/fulltext?rss=yes">
269.      <title>Surgical Coronary Revascularization in Patients With Underlying Atrial Fibrillation: State-of-the-Art Review</title>
270.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00606-7/fulltext?rss=yes</link>
271.      <description>The number of individuals referred for coronary artery bypass grafting (CABG) with preoperative atrial fibrillation (AF) is reported to be 8% to 20%. Atrial fibrillation is a known marker of high-risk patients as it was repeatedly found to negatively influence survival. Therefore, when performing surgical revascularization, consideration should be given to the concomitant treatment of the arrhythmia, the clinical consequences of the arrhythmia itself, and the selection of adequate surgical techniques.</description>
272.      <dc:title>Surgical Coronary Revascularization in Patients With Underlying Atrial Fibrillation: State-of-the-Art Review</dc:title>
273.      <dc:creator>Emil J. Dąbrowski, Anna Kurasz, Michał Pasierski, Luigi Pannone, Michalina M. Kołodziejczak, Giuseppe M. Raffa, Matteo Matteucci, Silvia Mariani, Maria E. de Piero, Mark La Meir, Bart Maessen, Paolo Meani, Patrick McCarthy, James L. Cox, Roberto Lorusso, Łukasz Kuźma, Scott J. Rankin, Piotr Suwalski, Mariusz Kowalewski, Thoracic Research Centre</dc:creator>
274.      <dc:identifier>10.1016/j.mayocp.2023.12.005</dc:identifier>
275.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
276.      <dc:date>2024-04-24</dc:date>
277.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
278.      <prism:publicationDate>2024-04-24</prism:publicationDate>
279.      <prism:section>Review</prism:section>
280.   </item>
281.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00599-2/fulltext?rss=yes">
282.      <title>Cardiorespiratory Fitness as a Predictor of Non–Cardiovascular Disease and Non-Cancer Mortality in Men</title>
283.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00599-2/fulltext?rss=yes</link>
284.      <description>To evaluate the association of 5 major cause-specific non–cardiovascular disease (CVD) and non-cancer deaths with cardiorespiratory fitness (CRF).</description>
285.      <dc:title>Cardiorespiratory Fitness as a Predictor of Non–Cardiovascular Disease and Non-Cancer Mortality in Men</dc:title>
286.      <dc:creator>Joshua R. Sparks, Xuewen Wang, Carl J. Lavie, Jiajia Zhang, Xuemei Sui</dc:creator>
287.      <dc:identifier>10.1016/j.mayocp.2023.11.024</dc:identifier>
288.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
289.      <dc:date>2024-04-24</dc:date>
290.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
291.      <prism:publicationDate>2024-04-24</prism:publicationDate>
292.      <prism:section>Original article</prism:section>
293.   </item>
294.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00564-5/fulltext?rss=yes">
295.      <title>Carpal Tunnel Syndrome and Transthyretin Amyloidosis in the All of Us Research Program</title>
296.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00564-5/fulltext?rss=yes</link>
297.      <description>To evaluate the association of carpal tunnel syndrome (CTS) with incident heart failure and incident amyloidosis and to assess the risk of CTS in pathogenic TTR genetic variant carriers.</description>
298.      <dc:title>Carpal Tunnel Syndrome and Transthyretin Amyloidosis in the All of Us Research Program</dc:title>
299.      <dc:creator>Naman S. Shetty, Akhil Pampana, Nirav Patel, Mathew S. Maurer, Parag Goyal, Peng Li, Garima Arora, Pankaj Arora</dc:creator>
300.      <dc:identifier>10.1016/j.mayocp.2023.11.016</dc:identifier>
301.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
302.      <dc:date>2024-04-24</dc:date>
303.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
304.      <prism:publicationDate>2024-04-24</prism:publicationDate>
305.      <prism:section>Original article</prism:section>
306.   </item>
307.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00476-7/fulltext?rss=yes">
308.      <title>CoaguChek and Coag-Sense PT2 Meter Point of Care INR Device Validation</title>
309.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00476-7/fulltext?rss=yes</link>
310.      <description>To standardize international normalized ratio (INR) measurements and improve data integrity by enabling electronic result transmission for warfarin monitoring, two point-of-care (POC) devices were evaluated against an internal plasma INR reference method.</description>
311.      <dc:title>CoaguChek and Coag-Sense PT2 Meter Point of Care INR Device Validation</dc:title>
312.      <dc:creator>Robert D. McBane, Carlee O’Connor, Jennifer Lutz, Jennifer Blanco, Levi A. Hartman, Anna Kramer, Josephine Uy, Traci Schumann, Katherine Hartung, Michael Luker, David Hodge, Paula Santrach, Brad S. Karon</dc:creator>
313.      <dc:identifier>10.1016/j.mayocp.2023.10.006</dc:identifier>
314.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
315.      <dc:date>2024-04-24</dc:date>
316.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
317.      <prism:publicationDate>2024-04-24</prism:publicationDate>
318.      <prism:section>Original Article</prism:section>
319.   </item>
320.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00406-8/fulltext?rss=yes">
321.      <title>Calf rEF: Impact of Calf Muscle Pump Dysfunction With Reduced Ejection Fraction on All-Cause Mortality</title>
322.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00406-8/fulltext?rss=yes</link>
323.      <description>To evaluate mortality outcomes by varying degrees of reduced calf muscle pump (CMP) ejection fraction (EF).</description>
324.      <dc:title>Calf rEF: Impact of Calf Muscle Pump Dysfunction With Reduced Ejection Fraction on All-Cause Mortality</dc:title>
325.      <dc:creator>Robert D. McBane, David Liedl, Waldemar Wysokinski, Paul W. Wennberg, Ana I. Casanegra, Atefeh Ghorbanzadeh, Adelaide Arruda-Olson, Christopher G. Scott, Alex T. Lee, Azza Ahmed, Thom W. Rooke, Damon E. Houghton</dc:creator>
326.      <dc:identifier>10.1016/j.mayocp.2023.08.013</dc:identifier>
327.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
328.      <dc:date>2024-04-24</dc:date>
329.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
330.      <prism:publicationDate>2024-04-24</prism:publicationDate>
331.      <prism:section>Original article</prism:section>
332.   </item>
333.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00610-9/fulltext?rss=yes">
334.      <title>Blood Calcium, Genetic Risk, and Risk of Incident Kidney Stone: A Population-Based Cohort Study</title>
335.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00610-9/fulltext?rss=yes</link>
336.      <description>To investigate the association between blood calcium concentration and incident kidney stone as well as to assess the role played by genetic susceptibility.</description>
337.      <dc:title>Blood Calcium, Genetic Risk, and Risk of Incident Kidney Stone: A Population-Based Cohort Study</dc:title>
338.      <dc:creator>Xi Cao, Si Li, Yunlong Guan, Zhonghe Shao, Minghui Jiang, Miao Wang, Xingjie Hao</dc:creator>
339.      <dc:identifier>10.1016/j.mayocp.2023.12.009</dc:identifier>
340.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
341.      <dc:date>2024-04-16</dc:date>
342.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
343.      <prism:publicationDate>2024-04-16</prism:publicationDate>
344.      <prism:section>Original Article</prism:section>
345.   </item>
346.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00037-5/fulltext?rss=yes">
347.      <title>Predicting Primary Care Physician Burnout From Electronic Health Record Use Measures</title>
348.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00037-5/fulltext?rss=yes</link>
349.      <description>To evaluate the ability of routinely collected electronic health record (EHR) use measures to predict clinical work units at increased risk of burnout and potentially most in need of targeted interventions.</description>
350.      <dc:title>Predicting Primary Care Physician Burnout From Electronic Health Record Use Measures</dc:title>
351.      <dc:creator>Daniel Tawfik, Mohsen Bayati, Jessica Liu, Liem Nguyen, Amrita Sinha, Thomas Kannampallil, Tait Shanafelt, Jochen Profit</dc:creator>
352.      <dc:identifier>10.1016/j.mayocp.2024.01.005</dc:identifier>
353.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
354.      <dc:date>2024-04-03</dc:date>
355.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
356.      <prism:publicationDate>2024-04-03</prism:publicationDate>
357.      <prism:section>Original article</prism:section>
358.   </item>
359.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00466-4/fulltext?rss=yes">
360.      <title>Incident Diuretic Use and Subsequent Risk of Bone Fractures</title>
361.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00466-4/fulltext?rss=yes</link>
362.      <description>To investigate the association of incident use of diuretics with subsequent risk of incident bone fractures.</description>
363.      <dc:title>Incident Diuretic Use and Subsequent Risk of Bone Fractures</dc:title>
364.      <dc:creator>Keiichi Sumida, Prabin Shrestha, Yamini Mallisetty, Satya Surbhi, Fridtjof Thomas, Elani Streja, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy</dc:creator>
365.      <dc:identifier>10.1016/j.mayocp.2023.09.018</dc:identifier>
366.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
367.      <dc:date>2024-04-03</dc:date>
368.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
369.      <prism:publicationDate>2024-04-03</prism:publicationDate>
370.      <prism:section>Original article</prism:section>
371.   </item>
372.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00035-1/fulltext?rss=yes">
373.      <title>Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women</title>
374.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00035-1/fulltext?rss=yes</link>
375.      <description>To quantify the burden of metabolic dysfunction–associated steatotic liver disease (MASLD) and related metabolic disorders in premenopausal women.</description>
376.      <dc:title>Metabolic Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease in Premenopausal Women</dc:title>
377.      <dc:creator>Pojsakorn Danpanichkul, Cheng Han Ng, Mark D. Muthiah, Kwanjit Duangsonk, Siwanart Kongarin, Karan Srisurapanont, Phakkamon Pingwang, Nonlawan Songmueang, Chalida Nonthasoot, Worapaka Manosroi, Surakit Nathisuwan, Fang Li, Ju Dong Yang, Vincent L. Chen, Donghee Kim, Mazen Noureddin, Daniel Q. Huang, Karn Wijarnpreecha</dc:creator>
378.      <dc:identifier>10.1016/j.mayocp.2023.12.025</dc:identifier>
379.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
380.      <dc:date>2024-03-28</dc:date>
381.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
382.      <prism:publicationDate>2024-03-28</prism:publicationDate>
383.      <prism:section>Original article</prism:section>
384.   </item>
385.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00602-X/fulltext?rss=yes">
386.      <title>Immunogammopathy Maculopathy</title>
387.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00602-X/fulltext?rss=yes</link>
388.      <description>A male in his mid-50s presented with painless and progressive blurred vision on his left eye for several weeks. The patient denied any comorbidities and past ophthalmic history. Best corrected visual acuity was 20/20 on his right eye and 20/40 on the left eye. The right eye examination was unremarkable. The left eye showed vascular and macular alterations (Figure 1). The patient underwent complete multimodal retinal imaging, including a normal indocyanine green angiography. Given this presentation, differentials included retinal, systemic, optic nerve, and inflammatory and neoplastic diseases.</description>
389.      <dc:title>Immunogammopathy Maculopathy</dc:title>
390.      <dc:creator>Luca Goncalves, Jose Pulido</dc:creator>
391.      <dc:identifier>10.1016/j.mayocp.2023.12.002</dc:identifier>
392.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
393.      <dc:date>2024-03-28</dc:date>
394.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
395.      <prism:publicationDate>2024-03-28</prism:publicationDate>
396.      <prism:volume>99</prism:volume>
397.      <prism:number>5</prism:number>
398.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
399.      <prism:section>Medical Image</prism:section>
400.      <prism:startingPage>844</prism:startingPage>
401.      <prism:endingPage>845</prism:endingPage>
402.   </item>
403.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00568-2/fulltext?rss=yes">
404.      <title>Laryngeal Amyloidosis</title>
405.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00568-2/fulltext?rss=yes</link>
406.      <description>Amyloidosis is a disease characterized by abnormal extracellular deposition of fibrillar proteins in tissues that creates a chronic inflammatory response leading to local tissue injury. The larynx is estimated to be involved in up to 15% of all amyloidosis cases.1 Symptoms of amyloidosis are nonspecific, and the diagnosis is determined by the severity and laryngeal site involved. It typically presents with dysphonia, but patients can also have dyspnea, stridor, odynophagia, cough, and hemoptysis.</description>
407.      <dc:title>Laryngeal Amyloidosis</dc:title>
408.      <dc:creator>Renata M. Knoll, Peter M. Sadow, Matthew R. Naunheim</dc:creator>
409.      <dc:identifier>10.1016/j.mayocp.2023.11.018</dc:identifier>
410.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
411.      <dc:date>2024-03-27</dc:date>
412.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
413.      <prism:publicationDate>2024-03-27</prism:publicationDate>
414.      <prism:volume>99</prism:volume>
415.      <prism:number>5</prism:number>
416.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
417.      <prism:section>Medical image</prism:section>
418.      <prism:startingPage>697</prism:startingPage>
419.      <prism:endingPage>698</prism:endingPage>
420.   </item>
421.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00367-1/fulltext?rss=yes">
422.      <title>50-Year-Old Man With Fevers, Cough, and Night Sweats</title>
423.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00367-1/fulltext?rss=yes</link>
424.      <description>A 50-year-old man presented to the emergency department in August with a 1-month history of progressive nonproductive cough, daily fevers, and drenching night sweats. His medical comorbidities included rheumatoid arthritis. Medications at the time of presentation included adalimumab and occasional acetaminophen as needed. He reported social alcohol use and no tobacco or recreational drug use. He endorsed intermittent headaches, mild dyspnea on exertion, several episodes of feeling off balance, and mild difficulties with short-term memory.</description>
425.      <dc:title>50-Year-Old Man With Fevers, Cough, and Night Sweats</dc:title>
426.      <dc:creator>Joelle N. Friesen, Alexandra Allman, Omar Abu Saleh</dc:creator>
427.      <dc:identifier>10.1016/j.mayocp.2023.07.030</dc:identifier>
428.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
429.      <dc:date>2024-03-27</dc:date>
430.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
431.      <prism:publicationDate>2024-03-27</prism:publicationDate>
432.      <prism:volume>99</prism:volume>
433.      <prism:number>5</prism:number>
434.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
435.      <prism:section>Residents’ clinic</prism:section>
436.      <prism:startingPage>821</prism:startingPage>
437.      <prism:endingPage>826</prism:endingPage>
438.   </item>
439.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00358-0/fulltext?rss=yes">
440.      <title>Efficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study</title>
441.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00358-0/fulltext?rss=yes</link>
442.      <description>To investigate whether hypotensive patients diagnosed with heart failure and reduced ejection fraction (HFrEF) might benefit from angiotensin receptor–neprilysin inhibitors (ARNis) in real-world practice because patients with baseline systolic blood pressure (SBP) of less than 100 mm Hg have been excluded from landmark trials.</description>
443.      <dc:title>Efficacy of Sacubitril-Valsartan on Survival and Cardiac Remodeling in Hypotensive Heart Failure With Reduced Ejection Fraction: A Multicenter Study</dc:title>
444.      <dc:creator>Chien-Yi Hsu, Fa-Po Chung, Chieh-Ju Chao, Ying-Ju Chen, Cho-Kai Wu, Yen-Wen Wu, Jin-Long Huang, Pao-Hsien Chu, Charles Jia-Yin Hou, Hung-Yu Chang, Chung-Lieh Hung</dc:creator>
445.      <dc:identifier>10.1016/j.mayocp.2023.07.023</dc:identifier>
446.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
447.      <dc:date>2024-03-26</dc:date>
448.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
449.      <prism:publicationDate>2024-03-26</prism:publicationDate>
450.      <prism:section>Original Article</prism:section>
451.   </item>
452.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00453-6/fulltext?rss=yes">
453.      <title>49-Year-Old Man With Melena and Abdominal Pain</title>
454.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00453-6/fulltext?rss=yes</link>
455.      <description>A 49-year-old man presented with a 6-day history of melena. During this time, he also experienced progressive fatigue, light-headedness and dyspnea on exertion, nausea, and a constant epigastric abdominal pain described as a cramping sensation that was unrelated to meals. He had experienced similar symptoms 6 years previously as well as 1 month prior to the current presentation. For the latter episode, he was evaluated at a local hospital where his hemoglobin level was determined to be 4.6 g/dL (reference range, 13.2 to 16.6 g/dL) and he underwent a blood transfusion.</description>
456.      <dc:title>49-Year-Old Man With Melena and Abdominal Pain</dc:title>
457.      <dc:creator>Bibek Saha, Alex P. Danielson, William C. Mundell</dc:creator>
458.      <dc:identifier>10.1016/j.mayocp.2023.09.006</dc:identifier>
459.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
460.      <dc:date>2024-03-24</dc:date>
461.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
462.      <prism:publicationDate>2024-03-24</prism:publicationDate>
463.      <prism:section>Residents’ clinic</prism:section>
464.   </item>
465.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00412-3/fulltext?rss=yes">
466.      <title>75-Year-Old Woman With Abdominal Distention</title>
467.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00412-3/fulltext?rss=yes</link>
468.      <description>A 75-year-old woman presented to the emergency department with progressive abdominal distention and pain. Her medical history includes colorectal cancer requiring left hemicolectomy and subsequent colostomy takedown 6 years before presentation at our center. She underwent open reduction with internal fixation of a right hip fracture 5 days before seeking emergency care and subsequently experienced gradual, progressive abdominal distention starting on postoperative day 1. She was passing gas and had a single small bowel movement on the day of discharge to inpatient rehabilitation.</description>
469.      <dc:title>75-Year-Old Woman With Abdominal Distention</dc:title>
470.      <dc:creator>Thomas Smith, James F. Howick V, Seth Sweetser</dc:creator>
471.      <dc:identifier>10.1016/j.mayocp.2023.08.019</dc:identifier>
472.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
473.      <dc:date>2024-03-24</dc:date>
474.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
475.      <prism:publicationDate>2024-03-24</prism:publicationDate>
476.      <prism:volume>99</prism:volume>
477.      <prism:number>5</prism:number>
478.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
479.      <prism:section>Residents’ clinic</prism:section>
480.      <prism:startingPage>832</prism:startingPage>
481.      <prism:endingPage>835</prism:endingPage>
482.   </item>
483.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00451-2/fulltext?rss=yes">
484.      <title>66-Year-Old Woman With Fatigue and Hypotension</title>
485.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00451-2/fulltext?rss=yes</link>
486.      <description>A 66-year-old woman presented to the emergency department with progressive fatigue, weakness, diarrhea, and hypotension of 3 weeks’ duration. Her symptoms had been gradually worsening without any clear inciting event. Her medical history was notable for ileocolonic stricturing Crohn disease treated with ileocecectomy 21 years previously, Charcot-Marie-Tooth disease (CMT), obesity, osteoporosis, depression, and dyslipidemia. Her medications had included alendronate, azathioprine for her Crohn disease, and paroxetine for depression, but she had stopped taking the latter 2 medications when her current symptoms started.</description>
487.      <dc:title>66-Year-Old Woman With Fatigue and Hypotension</dc:title>
488.      <dc:creator>Thomas W. Fredrick, Ruth E. DeFoster</dc:creator>
489.      <dc:identifier>10.1016/j.mayocp.2023.09.004</dc:identifier>
490.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
491.      <dc:date>2024-03-23</dc:date>
492.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
493.      <prism:publicationDate>2024-03-23</prism:publicationDate>
494.      <prism:section>Residents’ clinic</prism:section>
495.   </item>
496.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00414-7/fulltext?rss=yes">
497.      <title>19-Year-Old Man With Abdominal Pain, Vomiting, Bloody Diarrhea, and Rash</title>
498.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00414-7/fulltext?rss=yes</link>
499.      <description>A 19-year-old man presented to the emergency department with abdominal pain, bloody diarrhea, vomiting, and rash. His symptoms began 1 week prior with nausea, vomiting, and watery diarrhea. Over the next few days, he developed crampy lower abdominal pain and began noting blood in his stools. His diarrhea progressively worsened and by the time of presentation he was having 10 to 12 episodes daily, most of which were bloody. Throughout this period, he noted the appearance of scattered “bumps” over his trunk, arms, and legs.</description>
500.      <dc:title>19-Year-Old Man With Abdominal Pain, Vomiting, Bloody Diarrhea, and Rash</dc:title>
501.      <dc:creator>David L. Farrier, David Chiang, Amindra S. Arora</dc:creator>
502.      <dc:identifier>10.1016/j.mayocp.2023.08.021</dc:identifier>
503.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
504.      <dc:date>2024-03-23</dc:date>
505.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
506.      <prism:publicationDate>2024-03-23</prism:publicationDate>
507.      <prism:section>Residents’ clinic</prism:section>
508.   </item>
509.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00413-5/fulltext?rss=yes">
510.      <title>51-Year-Old Woman With Bloody Diarrhea</title>
511.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00413-5/fulltext?rss=yes</link>
512.      <description>A 51-year-old woman presented to the emergency department with bloody diarrhea and abdominal cramping. Symptoms began 5 days before presentation with initially nonbloody diarrhea. She had used over-the-counter loperamide with improvement of stool frequency; however, abdominal cramping persisted. Subsequently, diarrhea became more profuse and became bloody 2 days before presentation. She denied fever or rigor. Her medical history was notable for remote deep venous thrombosis, heterozygous factor V Leiden mutation, and class II obesity with distant history of gastric bypass.</description>
513.      <dc:title>51-Year-Old Woman With Bloody Diarrhea</dc:title>
514.      <dc:creator>Samantha E. Mannion, Clifford M. Csizmar, Sean R. Legler</dc:creator>
515.      <dc:identifier>10.1016/j.mayocp.2023.08.020</dc:identifier>
516.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
517.      <dc:date>2024-03-23</dc:date>
518.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
519.      <prism:publicationDate>2024-03-23</prism:publicationDate>
520.      <prism:volume>99</prism:volume>
521.      <prism:number>5</prism:number>
522.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
523.      <prism:section>Residents’ clinic</prism:section>
524.      <prism:startingPage>827</prism:startingPage>
525.      <prism:endingPage>831</prism:endingPage>
526.   </item>
527.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00572-4/fulltext?rss=yes">
528.      <title>County Rurality and Incidence and Prevalence of Diagnosed Diabetes in the United States</title>
529.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00572-4/fulltext?rss=yes</link>
530.      <description>To examine differences in the incidence and prevalence of diagnosed diabetes by county rurality.</description>
531.      <dc:title>County Rurality and Incidence and Prevalence of Diagnosed Diabetes in the United States</dc:title>
532.      <dc:creator>Sagar B. Dugani, Brian D. Lahr, Hui Xie, Michelle M. Mielke, Kent R. Bailey, Adrian Vella</dc:creator>
533.      <dc:identifier>10.1016/j.mayocp.2023.11.022</dc:identifier>
534.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
535.      <dc:date>2024-03-19</dc:date>
536.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
537.      <prism:publicationDate>2024-03-19</prism:publicationDate>
538.      <prism:section>Original article</prism:section>
539.   </item>
540.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00026-0/fulltext?rss=yes">
541.      <title>High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction</title>
542.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00026-0/fulltext?rss=yes</link>
543.      <description>To evaluate the diagnostic performance of the previously recommended baseline high-sensitivity cardiac troponin T (hs-cTnT) thresholds of 52 and 100 ng/L in identifying patients at high risk of acute myocardial infarction (AMI).</description>
544.      <dc:title>High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction</dc:title>
545.      <dc:creator>Jonathan D. Knott, Olatunde Ola, Laura De Michieli, Ashok Akula, Eric H. Yang, S. Michael Gharacholou, Josh Slusser, Bradley Lewis, Ramila A. Mehta, Rajiv Gulati, Yader Sandoval, Allan S. Jaffe</dc:creator>
546.      <dc:identifier>10.1016/j.mayocp.2023.12.019</dc:identifier>
547.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
548.      <dc:date>2024-03-16</dc:date>
549.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
550.      <prism:publicationDate>2024-03-16</prism:publicationDate>
551.      <prism:section>Original article</prism:section>
552.   </item>
553.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00341-5/fulltext?rss=yes">
554.      <title>Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery</title>
555.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00341-5/fulltext?rss=yes</link>
556.      <description>To explore admission and discharge prescription rates of guideline-directed medical therapy (GDMT), defined as aggregate antiplatelet agents, statins, and β-blockers, after coronary artery bypass graft (CABG) surgery and to reveal its association with long-term survival.</description>
557.      <dc:title>Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery</dc:title>
558.      <dc:creator>Yaron Moshkovitz, Liat Orenstein, Liraz Olmer, Keren Laufer, Arnona Ziv, Rachel Dankner</dc:creator>
559.      <dc:identifier>10.1016/j.mayocp.2023.06.022</dc:identifier>
560.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
561.      <dc:date>2024-03-06</dc:date>
562.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
563.      <prism:publicationDate>2024-03-06</prism:publicationDate>
564.      <prism:volume>99</prism:volume>
565.      <prism:number>5</prism:number>
566.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
567.      <prism:section>Original article</prism:section>
568.      <prism:startingPage>766</prism:startingPage>
569.      <prism:endingPage>779</prism:endingPage>
570.   </item>
571.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00469-X/fulltext?rss=yes">
572.      <title>Older Tissue Age Derived From Abdominal Computed Tomography Biomarkers of Muscle, Fat, and Bone Is Associated With Chronic Conditions and Higher Mortality</title>
573.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00469-X/fulltext?rss=yes</link>
574.      <description>To determine whether body composition derived from medical imaging may be useful for assessing biologic age at the tissue level because people of the same chronologic age may vary with respect to their biologic age.</description>
575.      <dc:title>Older Tissue Age Derived From Abdominal Computed Tomography Biomarkers of Muscle, Fat, and Bone Is Associated With Chronic Conditions and Higher Mortality</dc:title>
576.      <dc:creator>Andrew D. Rule, Brandon R. Grossardt, Alexander D. Weston, Hillary W. Garner, Timothy L. Kline, Alanna M. Chamberlain, Alina M. Allen, Bradley J. Erickson, Walter A. Rocca, Jennifer L. St. Sauver</dc:creator>
577.      <dc:identifier>10.1016/j.mayocp.2023.09.021</dc:identifier>
578.      <dc:source>Mayo Clinic Proceedings (2024)</dc:source>
579.      <dc:date>2024-02-02</dc:date>
580.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
581.      <prism:publicationDate>2024-02-02</prism:publicationDate>
582.      <prism:section>Original article</prism:section>
583.   </item>
584.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00304-X/fulltext?rss=yes">
585.      <title>Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation</title>
586.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00304-X/fulltext?rss=yes</link>
587.      <description>To compare outcomes after left atrial appendage occlusion (LAAO) via implanted device vs no LAAO in a matched cohort of patients with atrial fibrillation (AF).</description>
588.      <dc:title>Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation</dc:title>
589.      <dc:creator>Baptiste Maille, Pascal Defaye, Sid Ahmed Bentounes, Julien Herbert, Jean Michel Clerc, Bertrand Pierre, Olivier Torras, Jean Claude Deharo, Laurent Fauchier</dc:creator>
590.      <dc:identifier>10.1016/j.mayocp.2023.05.030</dc:identifier>
591.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
592.      <dc:date>2024-01-04</dc:date>
593.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
594.      <prism:publicationDate>2024-01-04</prism:publicationDate>
595.      <prism:volume>99</prism:volume>
596.      <prism:number>5</prism:number>
597.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
598.      <prism:section>Original article</prism:section>
599.      <prism:startingPage>754</prism:startingPage>
600.      <prism:endingPage>765</prism:endingPage>
601.   </item>
602.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00356-7/fulltext?rss=yes">
603.      <title>Hospital Outcomes in Medical Patients With Alcohol-Related and Non–Alcohol-Related Wernicke Encephalopathy</title>
604.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00356-7/fulltext?rss=yes</link>
605.      <description>To conduct a nationwide retrospective cohort study to assess trends and hospitalization-associated outcomes in patients with Wernicke encephalopathy.</description>
606.      <dc:title>Hospital Outcomes in Medical Patients With Alcohol-Related and Non–Alcohol-Related Wernicke Encephalopathy</dc:title>
607.      <dc:creator>Roshaani Rasiah, Claudia Gregoriano, Beat Mueller, Alexander Kutz, Philipp Schuetz</dc:creator>
608.      <dc:identifier>10.1016/j.mayocp.2023.07.021</dc:identifier>
609.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
610.      <dc:date>2023-12-08</dc:date>
611.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
612.      <prism:publicationDate>2023-12-08</prism:publicationDate>
613.      <prism:volume>99</prism:volume>
614.      <prism:number>5</prism:number>
615.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
616.      <prism:section>Original article</prism:section>
617.      <prism:startingPage>740</prism:startingPage>
618.      <prism:endingPage>753</prism:endingPage>
619.   </item>
620.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00373-7/fulltext?rss=yes">
621.      <title>Shock Severity Classification and Mortality in Adults With Cardiac, Medical, Surgical, and Neurological Critical Illness</title>
622.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00373-7/fulltext?rss=yes</link>
623.      <description>To evaluate whether the Society for Cardiovascular Angiography and Interventions (SCAI) Shock Classification could perform risk stratification in a mixed cohort of intensive care unit (ICU) patients, similar to its validation in patients with acute cardiac disease.</description>
624.      <dc:title>Shock Severity Classification and Mortality in Adults With Cardiac, Medical, Surgical, and Neurological Critical Illness</dc:title>
625.      <dc:creator>Jacob C. Jentzer, Devang Senghavi, Parag C. Patel, Anirban Bhattacharyya, Sean van Diepen, Vitaly Herasevich, Ognjen Gajic, Kianoush B. Kashani</dc:creator>
626.      <dc:identifier>10.1016/j.mayocp.2023.08.007</dc:identifier>
627.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
628.      <dc:date>2023-10-08</dc:date>
629.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
630.      <prism:publicationDate>2023-10-08</prism:publicationDate>
631.      <prism:volume>99</prism:volume>
632.      <prism:number>5</prism:number>
633.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
634.      <prism:section>Original article</prism:section>
635.      <prism:startingPage>727</prism:startingPage>
636.      <prism:endingPage>739</prism:endingPage>
637.   </item>
638.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00347-6/fulltext?rss=yes">
639.      <title>Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry</title>
640.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00347-6/fulltext?rss=yes</link>
641.      <description>To explore the association between metabolic status, body mass index (BMI), and natural history of patients with atrial fibrillation (AF).</description>
642.      <dc:title>Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry</dc:title>
643.      <dc:creator>Bernadette Corica, Giulio Francesco Romiti, Marco Proietti, Davide Antonio Mei, Giuseppe Boriani, Tze-Fan Chao, Brian Olshansky, Menno V. Huisman, Gregory Y.H. Lip, GLORIA-AF Investigators</dc:creator>
644.      <dc:identifier>10.1016/j.mayocp.2023.07.013</dc:identifier>
645.      <dc:source>Mayo Clinic Proceedings (2023)</dc:source>
646.      <dc:date>2023-08-25</dc:date>
647.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
648.      <prism:publicationDate>2023-08-25</prism:publicationDate>
649.      <prism:section>Original Article</prism:section>
650.   </item>
651.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00195-2/fulltext?rss=yes">
652.      <title>Highlights From the Current Issue – Audiovisual Summary</title>
653.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00195-2/fulltext?rss=yes</link>
654.      <description>Karl A. Nath, MBChB, Editor-in-Chief of Mayo Clinic Proceedings, discusses the Editor’s Choice and Highlights articles appearing in the May 2024 issue.</description>
655.      <dc:title>Highlights From the Current Issue – Audiovisual Summary</dc:title>
656.      <dc:creator>Karl A. Nath</dc:creator>
657.      <dc:identifier>10.1016/j.mayocp.2024.04.004</dc:identifier>
658.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
659.      <dc:date>2024-05</dc:date>
660.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
661.      <prism:publicationDate>2024-05</prism:publicationDate>
662.      <prism:volume>99</prism:volume>
663.      <prism:number>5</prism:number>
664.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
665.      <prism:section>Issue Summary</prism:section>
666.      <prism:startingPage>e1</prism:startingPage>
667.   </item>
668.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00173-3/fulltext?rss=yes">
669.      <title>General Information</title>
670.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00173-3/fulltext?rss=yes</link>
671.      <dc:title>General Information</dc:title>
672.      <dc:identifier>10.1016/S0025-6196(24)00173-3</dc:identifier>
673.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
674.      <dc:date>2024-05</dc:date>
675.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
676.      <prism:publicationDate>2024-05</prism:publicationDate>
677.      <prism:volume>99</prism:volume>
678.      <prism:number>5</prism:number>
679.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
680.      <prism:startingPage>A7</prism:startingPage>
681.   </item>
682.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00172-1/fulltext?rss=yes">
683.      <title>Table of Contents</title>
684.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00172-1/fulltext?rss=yes</link>
685.      <dc:title>Table of Contents</dc:title>
686.      <dc:identifier>10.1016/S0025-6196(24)00172-1</dc:identifier>
687.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
688.      <dc:date>2024-05</dc:date>
689.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
690.      <prism:publicationDate>2024-05</prism:publicationDate>
691.      <prism:volume>99</prism:volume>
692.      <prism:number>5</prism:number>
693.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
694.      <prism:startingPage>A3</prism:startingPage>
695.      <prism:endingPage>A6</prism:endingPage>
696.   </item>
697.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00171-X/fulltext?rss=yes">
698.      <title>Editorial Board</title>
699.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00171-X/fulltext?rss=yes</link>
700.      <dc:title>Editorial Board</dc:title>
701.      <dc:identifier>10.1016/S0025-6196(24)00171-X</dc:identifier>
702.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
703.      <dc:date>2024-05</dc:date>
704.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
705.      <prism:publicationDate>2024-05</prism:publicationDate>
706.      <prism:volume>99</prism:volume>
707.      <prism:number>5</prism:number>
708.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
709.      <prism:startingPage>A1</prism:startingPage>
710.      <prism:endingPage>A2</prism:endingPage>
711.   </item>
712.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00162-9/fulltext?rss=yes">
713.      <title>Sir Wilfred Thomason Grenfell: Medical Pioneer in Newfoundland and Labrador</title>
714.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00162-9/fulltext?rss=yes</link>
715.      <description>Stamp Vignettes focus on biographical details and accomplishments related to science and medicine, and not individual views and prejudices except where they had a major impact on the subject's life. The authors do not intend to imply any endorsement of such views when discussing a Stamp Vignette on Medical Science.</description>
716.      <dc:title>Sir Wilfred Thomason Grenfell: Medical Pioneer in Newfoundland and Labrador</dc:title>
717.      <dc:creator>David P. Steensma, Robert A. Kyle</dc:creator>
718.      <dc:identifier>10.1016/j.mayocp.2024.03.021</dc:identifier>
719.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
720.      <dc:date>2024-05</dc:date>
721.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
722.      <prism:publicationDate>2024-05</prism:publicationDate>
723.      <prism:volume>99</prism:volume>
724.      <prism:number>5</prism:number>
725.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
726.      <prism:section>Stamp vignette on medical science</prism:section>
727.      <prism:startingPage>849</prism:startingPage>
728.      <prism:endingPage>851</prism:endingPage>
729.   </item>
730.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00161-7/fulltext?rss=yes">
731.      <title>In the Limelight: May 2024</title>
732.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00161-7/fulltext?rss=yes</link>
733.      <description>This month’s feature highlights three articles that appear in the current issue of Mayo Clinic Proceedings. These articles are also featured on the Mayo Clinic Proceedings’ YouTube Channel (https://youtu.be/G-hg8TqQZMs).</description>
734.      <dc:title>In the Limelight: May 2024</dc:title>
735.      <dc:creator>Karl A. Nath</dc:creator>
736.      <dc:identifier>10.1016/j.mayocp.2024.03.020</dc:identifier>
737.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
738.      <dc:date>2024-05</dc:date>
739.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
740.      <prism:publicationDate>2024-05</prism:publicationDate>
741.      <prism:volume>99</prism:volume>
742.      <prism:number>5</prism:number>
743.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
744.      <prism:section>In the limelight</prism:section>
745.      <prism:startingPage>685</prism:startingPage>
746.      <prism:endingPage>687</prism:endingPage>
747.   </item>
748.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00147-2/fulltext?rss=yes">
749.      <title>Oracle, Merakai, Appollo, Yang by Claire Roche</title>
750.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00147-2/fulltext?rss=yes</link>
751.      <description>Art is integrated into the Mayo Clinic environment. Since the original Mayo Clinic Building was finished in 1914, many pieces have been donated or commissioned for patients and staff to enjoy. Each issue of Mayo Clinic Proceedings features a work of art (as interpreted by the author) that is displayed in a building or on the grounds of Mayo Clinic campuses.</description>
752.      <dc:title>Oracle, Merakai, Appollo, Yang by Claire Roche</dc:title>
753.      <dc:creator>Margaret R. Wentz</dc:creator>
754.      <dc:identifier>10.1016/j.mayocp.2024.03.011</dc:identifier>
755.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
756.      <dc:date>2024-05</dc:date>
757.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
758.      <prism:publicationDate>2024-05</prism:publicationDate>
759.      <prism:volume>99</prism:volume>
760.      <prism:number>5</prism:number>
761.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
762.      <prism:section>Art at mayo clinic</prism:section>
763.      <prism:startingPage>852</prism:startingPage>
764.      <prism:endingPage>853</prism:endingPage>
765.   </item>
766.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00136-8/fulltext?rss=yes">
767.      <title>Improving Kidney Transplant Rates in Obese CKD Patients by Sleeve Gastrectomy</title>
768.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00136-8/fulltext?rss=yes</link>
769.      <description>Obesity is a central obstacle to health and wellness in people with chronic kidney disease (CKD). It is linked to progression of CKD, a greater burden of disease and disability, and reduced access to kidney transplant.1-3 Moreover, obesity is a common condition in CKD, being seen in nearly 50% of individuals with CKD stages 3 and 4.4 As a highly prevalent and major risk factor for adverse outcomes, obesity has been receiving increasing attention from the nephrology community as an urgent problem that needs addressing.</description>
770.      <dc:title>Improving Kidney Transplant Rates in Obese CKD Patients by Sleeve Gastrectomy</dc:title>
771.      <dc:creator>Allon N. Friedman</dc:creator>
772.      <dc:identifier>10.1016/j.mayocp.2024.03.004</dc:identifier>
773.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
774.      <dc:date>2024-05</dc:date>
775.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
776.      <prism:publicationDate>2024-05</prism:publicationDate>
777.      <prism:volume>99</prism:volume>
778.      <prism:number>5</prism:number>
779.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
780.      <prism:section>Editorial</prism:section>
781.      <prism:startingPage>688</prism:startingPage>
782.      <prism:endingPage>690</prism:endingPage>
783.   </item>
784.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00135-6/fulltext?rss=yes">
785.      <title>Opioids and Accelerated Brain Aging: The White Matter Matters</title>
786.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00135-6/fulltext?rss=yes</link>
787.      <description>Opioids are most highly prescribed in older adults, and because of aging and multimorbidity, this demographic is also most likely to suffer adverse events from this drug class. The article by Warner et al1 reports on the cross-sectional associations between prescription opioid exposures in community-dwelling older adults (older than 65 years) and gray and white matter structure assessed by magnetic resonance imaging. The primary exposure was the duration of opioid availability with a secondary exposure of total morphine milligram equivalents (MME).</description>
788.      <dc:title>Opioids and Accelerated Brain Aging: The White Matter Matters</dc:title>
789.      <dc:creator>Robert J. Pignolo</dc:creator>
790.      <dc:identifier>10.1016/j.mayocp.2024.03.003</dc:identifier>
791.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
792.      <dc:date>2024-05</dc:date>
793.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
794.      <prism:publicationDate>2024-05</prism:publicationDate>
795.      <prism:volume>99</prism:volume>
796.      <prism:number>5</prism:number>
797.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
798.      <prism:section>Editorial</prism:section>
799.      <prism:startingPage>691</prism:startingPage>
800.      <prism:endingPage>692</prism:endingPage>
801.   </item>
802.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00134-4/fulltext?rss=yes">
803.      <title>Physician Coaching: Establishing Standards and Core Competencies</title>
804.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00134-4/fulltext?rss=yes</link>
805.      <description>These are dynamic and challenging times for physicians. Changes to practice structures within health care have decreased autonomy and flexibility, leaving many physicians feeling as if they are cogs in the wheel of an impersonal system. Other structural changes to health care delivery have also contributed to frustration, eroded meaning in work, and occupational distress for many physicians.</description>
806.      <dc:title>Physician Coaching: Establishing Standards and Core Competencies</dc:title>
807.      <dc:creator>Kerri Palamara, Tait D. Shanafelt</dc:creator>
808.      <dc:identifier>10.1016/j.mayocp.2024.03.002</dc:identifier>
809.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
810.      <dc:date>2024-05</dc:date>
811.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
812.      <prism:publicationDate>2024-05</prism:publicationDate>
813.      <prism:volume>99</prism:volume>
814.      <prism:number>5</prism:number>
815.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
816.      <prism:section>Editorial</prism:section>
817.      <prism:startingPage>693</prism:startingPage>
818.      <prism:endingPage>696</prism:endingPage>
819.   </item>
820.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00107-1/fulltext?rss=yes">
821.      <title>Sebaceous Neoplasm With Defective DNA Mismatch Repair</title>
822.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00107-1/fulltext?rss=yes</link>
823.      <description>A woman in her 70s presented with a cutaneous lesion composed of a mixture of basaloid cells and sebocytes arranged in lobules, most consistent with a sebaceous adenoma (Figure 1). Immunohistochemistry for mismatch repair genes showed loss of nuclear expression of MSH2 and MSH6 in the tumor cells. Representative images are depicted in Figure 2. Microsatellite instability testing showed instability in all of the 7 informative markers analyzed, indicative of defective DNA mismatch repair function within the tumor.</description>
824.      <dc:title>Sebaceous Neoplasm With Defective DNA Mismatch Repair</dc:title>
825.      <dc:creator>Burak Tekin, Sounak Gupta, Lori A. Erickson</dc:creator>
826.      <dc:identifier>10.1016/j.mayocp.2024.02.021</dc:identifier>
827.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
828.      <dc:date>2024-05</dc:date>
829.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
830.      <prism:publicationDate>2024-05</prism:publicationDate>
831.      <prism:volume>99</prism:volume>
832.      <prism:number>5</prism:number>
833.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
834.      <prism:section>Path to patient image quiz</prism:section>
835.      <prism:startingPage>846</prism:startingPage>
836.      <prism:endingPage>848</prism:endingPage>
837.   </item>
838.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00088-0/fulltext?rss=yes">
839.      <title>New Developments in Psychiatric Boarding in Emergency Departments</title>
840.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00088-0/fulltext?rss=yes</link>
841.      <description>In July 2023, the New Hampshire Department of Health and Human Services and a group of New Hampshire hospitals reached a settlement in a 5-year-long legal dispute over the practice of psychiatric boarding in hospital emergency departments. The hospitals successfully made the novel argument that boarding violates their rights, as well as those of patients. The case is a new and significant development in the legal battles among patients, advocates, hospitals, and states that have arisen as psychiatric boarding remains a pervasive challenge in American emergency departments.</description>
842.      <dc:title>New Developments in Psychiatric Boarding in Emergency Departments</dc:title>
843.      <dc:creator>Michael J. Redinger, Tyler S. Gibb, Kathryn E. Redinger</dc:creator>
844.      <dc:identifier>10.1016/j.mayocp.2024.02.004</dc:identifier>
845.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
846.      <dc:date>2024-05</dc:date>
847.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
848.      <prism:publicationDate>2024-05</prism:publicationDate>
849.      <prism:volume>99</prism:volume>
850.      <prism:number>5</prism:number>
851.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
852.      <prism:section>Commentary</prism:section>
853.      <prism:startingPage>699</prism:startingPage>
854.      <prism:endingPage>701</prism:endingPage>
855.   </item>
856.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00083-1/fulltext?rss=yes">
857.      <title>Sclerosing Mesenteritis: A Concise Clinical Review for Clinicians</title>
858.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00083-1/fulltext?rss=yes</link>
859.      <description>Sclerosing mesenteritis (SM), an idiopathic nonneoplastic condition affecting 0.18% to 3.14% of the population, is characterized by chronic fat necrosis, inflammation, and fibrosis most commonly of the mesentery of the small intestine. Sclerosing mesenteritis typically presents in the fifth or sixth decade of life, where patients with a history of abdominal surgery and/or autoimmune disease may be at higher risk. While many patients are asymptomatic, clinical features and complications are related to the mass effect resulting from the inflammation and fibrosis involved in the pathogenesis of SM.</description>
860.      <dc:title>Sclerosing Mesenteritis: A Concise Clinical Review for Clinicians</dc:title>
861.      <dc:creator>Bibek Saha, June Tome, Xiao Jing Wang</dc:creator>
862.      <dc:identifier>10.1016/j.mayocp.2024.01.019</dc:identifier>
863.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
864.      <dc:date>2024-05</dc:date>
865.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
866.      <prism:publicationDate>2024-05</prism:publicationDate>
867.      <prism:volume>99</prism:volume>
868.      <prism:number>5</prism:number>
869.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
870.      <prism:section>Concise review</prism:section>
871.      <prism:startingPage>812</prism:startingPage>
872.      <prism:endingPage>820</prism:endingPage>
873.   </item>
874.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00054-5/fulltext?rss=yes">
875.      <title>Prescription Opioids and Brain Structure in Community-Dwelling Older Adults</title>
876.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00054-5/fulltext?rss=yes</link>
877.      <description>To evaluate the associations between prescription opioid exposures in community-dwelling older adults and gray and white matter structure by magnetic resonance imaging.</description>
878.      <dc:title>Prescription Opioids and Brain Structure in Community-Dwelling Older Adults</dc:title>
879.      <dc:creator>Nafisseh S. Warner, Andrew C. Hanson, Phillip J. Schulte, Firat Kara, Robert I. Reid, Christopher G. Schwarz, Eduardo E. Benarroch, Jonathan Graff-Radford, Prashanthi Vemuri, Clifford R. Jack, Ronald C. Petersen, David O. Warner, Michelle M. Mielke, Kejal Kantarci</dc:creator>
880.      <dc:identifier>10.1016/j.mayocp.2024.01.018</dc:identifier>
881.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
882.      <dc:date>2024-05</dc:date>
883.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
884.      <prism:publicationDate>2024-05</prism:publicationDate>
885.      <prism:volume>99</prism:volume>
886.      <prism:number>5</prism:number>
887.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
888.      <prism:section>Original article</prism:section>
889.      <prism:startingPage>716</prism:startingPage>
890.      <prism:endingPage>726</prism:endingPage>
891.   </item>
892.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00053-3/fulltext?rss=yes">
893.      <title>Weight Loss Surgery Increases Kidney Transplant Rates in Patients With Renal Failure and Obesity</title>
894.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00053-3/fulltext?rss=yes</link>
895.      <description>To describe the outcomes of kidney transplant (KT) candidates with obesity undergoing sleeve gastrectomy (SG) to meet the criteria for KT.</description>
896.      <dc:title>Weight Loss Surgery Increases Kidney Transplant Rates in Patients With Renal Failure and Obesity</dc:title>
897.      <dc:creator>Aleksandra Kukla, Sukhdeep S. Sahi, Pavel Navratil, Roberto P. Benzo, Byron H. Smith, Dustin Duffy, Walter D. Park, Meera Shah, Pankaj Shah, Matthew M. Clark, David C. Fipps, Aleksandar Denic, Carrie A. Schinstock, Patrick G. Dean, Mark D. Stegall, Yogish C. Kudva, Tayyab S. Diwan</dc:creator>
898.      <dc:identifier>10.1016/j.mayocp.2024.01.017</dc:identifier>
899.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
900.      <dc:date>2024-05</dc:date>
901.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
902.      <prism:publicationDate>2024-05</prism:publicationDate>
903.      <prism:volume>99</prism:volume>
904.      <prism:number>5</prism:number>
905.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
906.      <prism:section>Original article</prism:section>
907.      <prism:startingPage>705</prism:startingPage>
908.      <prism:endingPage>715</prism:endingPage>
909.   </item>
910.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00048-X/fulltext?rss=yes">
911.      <title>Acute and Complicated Inflammatory Pericarditis</title>
912.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00048-X/fulltext?rss=yes</link>
913.      <description>Inflammatory disease of the pericardium represents a relatively common presentation, especially among the young. For the most part, inflammatory pericardial disease can be expeditiously and effectively managed without significant sequelae. However, some individuals present with severe and recurrent illness, representing significant therapeutic challenges. During the past decade, there have been great strides made in developing an evidence-based approach to management of inflammatory pericardial disease, the result of which has been the development of (1) a systematic, protocoled approach to initial care; (2) targeted therapeutics; and (3) specialized, collaborative, and integrated care pathways.</description>
914.      <dc:title>Acute and Complicated Inflammatory Pericarditis</dc:title>
915.      <dc:creator>Awais A. Malik, James W. Lloyd, Nandan S. Anavekar, Sushil Allen Luis</dc:creator>
916.      <dc:identifier>10.1016/j.mayocp.2024.01.012</dc:identifier>
917.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
918.      <dc:date>2024-05</dc:date>
919.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
920.      <prism:publicationDate>2024-05</prism:publicationDate>
921.      <prism:volume>99</prism:volume>
922.      <prism:number>5</prism:number>
923.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
924.      <prism:section>Review</prism:section>
925.      <prism:startingPage>795</prism:startingPage>
926.      <prism:endingPage>811</prism:endingPage>
927.   </item>
928.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00033-8/fulltext?rss=yes">
929.      <title>Competencies for Those Who Coach Physicians: A Modified Delphi Study</title>
930.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00033-8/fulltext?rss=yes</link>
931.      <description>The rapidly evolving coaching profession has permeated the health care industry and is gaining ground as a viable solution for addressing physician burnout, turnover, and leadership crises that plague the industry. Although various coach credentialing bodies are established, the profession has no standardized competencies for physician coaching as a specialty practice area, creating a market of aspiring coaches with varying degrees of expertise. To address this gap, we employed a modified Delphi approach to arrive at expert consensus on competencies necessary for coaching physicians and physician leaders.</description>
932.      <dc:title>Competencies for Those Who Coach Physicians: A Modified Delphi Study</dc:title>
933.      <dc:creator>Angela M. Passarelli, Gail Gazelle, Leslie E. Schwab, Robert F. Kramer, Margaret A. Moore, Raja G. Subhiyah, Nicole M. Deiorio, Mamta Gautam, Priscilla Gill, Sharon K. Hull, Cara R. King, Andrea Sikon</dc:creator>
934.      <dc:identifier>10.1016/j.mayocp.2024.01.002</dc:identifier>
935.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
936.      <dc:date>2024-05</dc:date>
937.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
938.      <prism:publicationDate>2024-05</prism:publicationDate>
939.      <prism:volume>99</prism:volume>
940.      <prism:number>5</prism:number>
941.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
942.      <prism:section>Special article</prism:section>
943.      <prism:startingPage>782</prism:startingPage>
944.      <prism:endingPage>794</prism:endingPage>
945.   </item>
946.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(24)00032-6/fulltext?rss=yes">
947.      <title>Focused Monitoring After Heart Failure Trials</title>
948.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(24)00032-6/fulltext?rss=yes</link>
949.      <description>Cardiovascular death and hospitalization for heart failure (HF) are prevailing end points in randomized controlled trials (RCTs) in patients who have HF with reduced ejection fraction (HFrEF). The low incidence of cardiovascular death and hospitalization in recent RCTs contrasts with the 5-year mortality rate of 75.5% and readmission risk of 48.5% among hospitalized HFrEF patients, indicating enrollment of stable New York Heart Association (NYHA) class II-III patients.1,2 However, inclusive enrollment in RCTs may yield incomplete therapeutic information.</description>
950.      <dc:title>Focused Monitoring After Heart Failure Trials</dc:title>
951.      <dc:creator>Thierry H. Le Jemtel, Rohan Samson</dc:creator>
952.      <dc:identifier>10.1016/j.mayocp.2024.01.001</dc:identifier>
953.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
954.      <dc:date>2024-05</dc:date>
955.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
956.      <prism:publicationDate>2024-05</prism:publicationDate>
957.      <prism:volume>99</prism:volume>
958.      <prism:number>5</prism:number>
959.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
960.      <prism:section>Perspective and controversy</prism:section>
961.      <prism:startingPage>702</prism:startingPage>
962.      <prism:endingPage>704</prism:endingPage>
963.   </item>
964.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00601-8/fulltext?rss=yes">
965.      <title>Capillary Telangiectasia</title>
966.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00601-8/fulltext?rss=yes</link>
967.      <description>A female in her late 40s presented for a second opinion regarding a pontine lesion concerning for a possible glial neoplasm that has been present for at least 10 years by imaging. Prior magnetic resonance imaging scans showed a solitary well-circumscribed T1-hypointense and subtle T2/T2-fluid-attenuated inversion recovery hyperintense lesion in the lower pons with homogenous gadolinium enhancement but no overt hemosiderin deposition on gradient echo sequence and no evidence of any other suspicious lesions in the brain or spinal cord.</description>
968.      <dc:title>Capillary Telangiectasia</dc:title>
969.      <dc:creator>Ehab Harahsheh, Justin Cramer</dc:creator>
970.      <dc:identifier>10.1016/j.mayocp.2023.12.001</dc:identifier>
971.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
972.      <dc:date>2024-05</dc:date>
973.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
974.      <prism:publicationDate>2024-05</prism:publicationDate>
975.      <prism:volume>99</prism:volume>
976.      <prism:number>5</prism:number>
977.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
978.      <prism:section>Medical image</prism:section>
979.      <prism:startingPage>780</prism:startingPage>
980.      <prism:endingPage>781</prism:endingPage>
981.   </item>
982.   <item rdf:about="https://www.mayoclinicproceedings.org/article/S0025-6196(23)00422-6/fulltext?rss=yes">
983.      <title>Physician Health Series Part One: Characteristics of Physicians as Patients</title>
984.      <link>https://www.mayoclinicproceedings.org/article/S0025-6196(23)00422-6/fulltext?rss=yes</link>
985.      <description>This is the first article of a 3-part series about physician health. In this installment, we outline the unique characteristics of physicians as patients, challenges and opportunities presented by physician-patients, and recommendations for treating physicians. Future articles will delve into role clarity, occupational considerations, mental health, and interactions with third parties such as the physician’s employer or licensing board. Ultimately, this series will help treating clinicians provide the best care to their physician-patients and successfully navigate the unique challenges that may arise, especially when the diagnosis may have an impact on their ability to practice medicine.</description>
986.      <dc:title>Physician Health Series Part One: Characteristics of Physicians as Patients</dc:title>
987.      <dc:creator>Greg P. Couser, Philip T. Hagen, Melanie D. Swift, Richard D. Newcomb, Clayton T. Cowl</dc:creator>
988.      <dc:identifier>10.1016/j.mayocp.2023.08.027</dc:identifier>
989.      <dc:source>Mayo Clinic Proceedings 99, 5 (2024)</dc:source>
990.      <dc:date>2024-05</dc:date>
991.      <prism:publicationName>Mayo Clinic Proceedings</prism:publicationName>
992.      <prism:publicationDate>2024-05</prism:publicationDate>
993.      <prism:volume>99</prism:volume>
994.      <prism:number>5</prism:number>
995.      <prism:issueIdentifier>S0025-6196(24)X0005-1</prism:issueIdentifier>
996.      <prism:section>Thematic Review on Physician Health</prism:section>
997.      <prism:startingPage>836</prism:startingPage>
998.      <prism:endingPage>843</prism:endingPage>
999.   </item>
1000. </rdf:RDF>
1001.  

If you would like to create a banner that links to this page (i.e. this validation result), do the following:

1. Download the "valid RSS" banner.

2. Upload the image to your own server. (This step is important. Please do not link directly to the image on this server.)

3. Add this HTML to your page (change the image src attribute if necessary):

   <a href="http://www.feedvalidator.org/check.cgi?url=http%3A//www.mayoclinicproceedings.org/current.rss"><img src="valid-rss.png" alt="[Valid RSS]" title="Validate my RSS feed" /></a>

If you would like to create a text link instead, here is the URL you can use:

http://www.feedvalidator.org/check.cgi?url=http%3A//www.mayoclinicproceedings.org/current.rss

Home · About · News · Docs · Terms